1. Combination therapy in cancer: effects of angiogenesis inhibitors on drug pharmacokinetics and pharmacodynamics. Issue 1 (29th June 2016) Authors: Fuso Nerini, Ilaria; Cesca, Marta; Bizzaro, Francesca; Giavazzi, Raffaella Journal: Cancer communications Issue: Volume 35:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Combination therapy in cancer: effects of angiogenesis inhibitors on drug pharmacokinetics and pharmacodynamics. Issue 1 (December 2016) Authors: Fuso Nerini, Ilaria; Cesca, Marta; Bizzaro, Francesca; Giavazzi, Raffaella Journal: Chinese journal of cancer Issue: Volume 35:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Expression of thrombospondin-1 by tumor cells in patient-derived ovarian carcinoma xenografts. (3rd September 2015) Authors: Pinessi, Denise; Ostano, Paola; Borsotti, Patrizia; Bello, Ezia; Guffanti, Federica; Bizzaro, Francesca; Frapolli, Roberta; Bani, Maria Rosa; Chiorino, Giovanna; Taraboletti, Giulia; Resovi, Andrea Journal: Connective tissue research Issue: Volume 56:Number 5(2015:Oct.) Page Start: 355 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Integrated molecular profiling of patient‐derived ovarian cancer models identifies clinically relevant signatures and tumor vulnerabilities. Issue 2 (14th March 2022) Authors: Lupia, Michela; Melocchi, Valentina; Bizzaro, Francesca; Lo Riso, Pietro; Dama, Elisa; Baronio, Micol; Ranghiero, Alberto; Barberis, Massimo; Bernard, Loris; Bertalot, Giovanni; Giavazzi, Raffaella; Testa, Giuseppe; Bianchi, Fabrizio; Cavallaro, Ugo Journal: International journal of cancer Issue: Volume 151:Issue 2(2022) Page Start: 240 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Tumor progression and metastatic dissemination in ovarian cancer after dose‐dense or conventional paclitaxel and cisplatin plus bevacizumab. Issue 9 (7th August 2018) Authors: Bizzaro, Francesca; Falcetta, Francesca; D'Agostini, Elisa; Decio, Alessandra; Minoli, Lucia; Erba, Eugenio; Alessandro Peccatori, Fedro; Scanziani, Eugenio; Colombo, Nicoletta; Zucchetti, Massimo; Bani, Maria Rosa; Ubezio, Paolo; Giavazzi, Raffaella Journal: International journal of cancer Issue: Volume 143:Issue 9(2018) Page Start: 2187 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗